There is anecdotal evidence of a plethora of guidelines developed throughout the NHS. A national survey was carried out between March and June 1995 to identify the number of clinical guidelines produced in the UK in the clinical areas of coronary heart disease, asthma, breast cancer, lung cancer and depression. The response to the survey ranged from 95% (interest groups) to 10% (Ministry of Defence and prison hospitals). Four hundred and seventy two guidelines were identified in the survey. Most had been produced locally, only 21 guidelines were classified as national. Results confirm that there is a proliferation of guidelines in most parts of the UK. The survey illustrates the difficulties involved in conducting a UK survey of this kind, and highlights the need for national guideline coordination.
Article navigation
1 April 1997
This article was originally published in
Journal of Clinical Effectiveness
Review Article|
April 01 1997
National survey of UK clinical guidelines for the management of coronary heart disease, lung and breast cancer, asthma and depression
Françoise Cluzeau;
Françoise Cluzeau
Health Care Evaluation Unit, St Georges Hospital Medical School, London
Search for other works by this author on:
Peter Littlejohns;
Peter Littlejohns
Health Care Evaluation Unit, St Georges Hospital Medical School, London
Search for other works by this author on:
Jeremy Grimshaw;
Jeremy Grimshaw
Health Services Research Unit, University of Aberdeen
Search for other works by this author on:
Gene Feder
Gene Feder
Department of General Practice and Primary Care, St Bartholomew's & The Royal London Hospital School of Medicine and Dentistry, London
Search for other works by this author on:
Publisher: Emerald Publishing
Online ISSN: 2396-9148
Print ISSN: 1361-5874
© MCB UP Limited
1997
Journal of Clinical Effectiveness (1997) 2 (4): 120–123.
Citation
Cluzeau F, Littlejohns P, Grimshaw J, Feder G (1997), "National survey of UK clinical guidelines for the management of coronary heart disease, lung and breast cancer, asthma and depression". Journal of Clinical Effectiveness, Vol. 2 No. 4 pp. 120–123, doi: https://doi.org/10.1108/eb043377
Download citation file:
151
Views
Suggested Reading
Cost-effectiveness and efficacy analysis of biosimilar drugs for lung diseases: a systematic review
Journal of Economic Studies (August,2025)
Inhibitory effects of catechin isolated from Acacia catechu on ovalbumin induced allergic asthma model: Role of histidine decarboxylase
Nutrition & Food Science (November,2018)
A computerized surveillance system for asthma
Int J Health Care Qual Assur (May,2011)
Transboundary air pollution and respiratory disease mortality: evidence from European countries
Journal of Economic Studies (November,2020)
Is there alignment amongst scientific literature, news media and patient forums regarding topics?: A study of breast and lung cancer
Online Information Review (February,2021)
Related Chapters
Lung Disease Detection Using Hybrid Machine Learning Algorithms
Innovations in Computational Intelligence, Big Data Analytics, and Internet of Things
Contextual, Ecological, and Organizational Variations in Risk-Adjusted COPD and Asthma Hospitalization Rates of Rural Medicare Beneficiaries
Special Social Groups, Social Factors and Disparities in Health and Health Care
ABOUT THE AUTHORS
Authority in Contention
Recommended for you
These recommendations are informed by your reading behaviors and indicated interests.
